Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Madersbacher

Showing results (31-40 of 375) with videos related to

Pageof 38
Sort By:
Current Opinion in Urology|November 14, 2014
Medical treatment of lower urinary tract symptoms/benign prostatic hyperplasia: anything new in 2015Ingrid Schauer, Stephan Madersbacher
BJU International|October 11, 2012
Landmarks in hormonal therapy for prostate cancerPeter Hammerer, Stephan Madersbacher
World Journal of Urology|January 5, 2002
Efficacy, tolerability and safety profile of propiverine in the treatment of the overactive bladder (non-neurogenic and neurogenic)H Madersbacher, G Mürtz
Paraplegia|June 1, 1984
Urodynamic practice in neuro-urological patients: techniques and clinical valueH Madersbacher, P Dietl
Methods (San Diego, Calif.)|April 15, 2000
Antibodies and immunoassaysS Madersbacher, P Berger
Therapeutische Umschau. Revue Therapeutique|March 7, 2006
[Epidemiology of BPH and medication approaches]M Marszalek, S Madersbacher
Neurourology and Urodynamics|March 6, 2013
Factors implicated in pathogenesis of urinary tract infections in neurogenic bladders: some revered, few forgotten, others ignoredPawan Vasudeva, Helmut Madersbacher
Der Internist|April 12, 2007
[Benign prostate hyperplasia: success and limitations of pharmacological therapy]S Madersbacher, M Marszalek
Current Opinion in Urology|November 6, 2009
Botulinum neurotoxin A for benign prostatic hyperplasiaAthanassios Oeconomou, Helmut Madersbacher
Der Urologe. Ausg. A|September 1, 1986
[Recurrent urinary incontinence: cystomanometry--conditio sine qua non?]H Madersbacher, A Ebner
Pageof 38

Showing results (31-40 of 375) with videos related to

Sort By:
Pageof 38
Current Opinion in Urology|November 14, 2014
Medical treatment of lower urinary tract symptoms/benign prostatic hyperplasia: anything new in 2015Ingrid Schauer, Stephan Madersbacher
BJU International|October 11, 2012
Landmarks in hormonal therapy for prostate cancerPeter Hammerer, Stephan Madersbacher
World Journal of Urology|January 5, 2002
Efficacy, tolerability and safety profile of propiverine in the treatment of the overactive bladder (non-neurogenic and neurogenic)H Madersbacher, G Mürtz
Paraplegia|June 1, 1984
Urodynamic practice in neuro-urological patients: techniques and clinical valueH Madersbacher, P Dietl
Methods (San Diego, Calif.)|April 15, 2000
Antibodies and immunoassaysS Madersbacher, P Berger
Therapeutische Umschau. Revue Therapeutique|March 7, 2006
[Epidemiology of BPH and medication approaches]M Marszalek, S Madersbacher
Neurourology and Urodynamics|March 6, 2013
Factors implicated in pathogenesis of urinary tract infections in neurogenic bladders: some revered, few forgotten, others ignoredPawan Vasudeva, Helmut Madersbacher
Der Internist|April 12, 2007
[Benign prostate hyperplasia: success and limitations of pharmacological therapy]S Madersbacher, M Marszalek
Current Opinion in Urology|November 6, 2009
Botulinum neurotoxin A for benign prostatic hyperplasiaAthanassios Oeconomou, Helmut Madersbacher
Der Urologe. Ausg. A|September 1, 1986
[Recurrent urinary incontinence: cystomanometry--conditio sine qua non?]H Madersbacher, A Ebner
Pageof 38